Catapres (Clonidine Hydrochloride) - Summary

CATAPRES SUMMARY

Catapres^®
(clonidine hydrochloride USP)

CATAPRES^® (clonidine hydrochloride USP) is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg and 0.3 mg. The 0.1 mg tablet is equivalent to 0.087 mg of the free base.

CATAPRES^® (clonidine hydrochloride USP) is indicated in the treatment of hypertension. CATAPRES may be employed alone or concomitantly with other antihypertensive agents.

CATAPRES NEWS HIGHLIGHTS

Media Articles Related to Catapres (Clonidine)

ADHD in Children: Is Clonidine Safe for Children?
Source: MedicineNet clonidine Specialty [2007.02.20]

more>>

Published Studies Related to Catapres (Clonidine)

Clonidine and analgesic duration after popliteal fossa nerve blockade: randomized, double-blind, placebo-controlled study. [2008.06]

The effect of clonidine infusion on distribution of regional cerebral blood flow in volunteers. [2008.03]

Intrathecal low-dose hyperbaric bupivacaine-clonidine combination in outpatient knee arthroscopy: a randomized controlled trial. [2008.03]

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. [2008.02]

Lidocaine+clonidine for maxillary infiltration anaesthesia: parameters of anaesthesia and vascular effects. [2008.02]

more>>

Clinical Trials Related to Catapres (Clonidine)

Clonidine Versus Midazolam for Premedication [Completed]

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome [Completed]

Epidural Fentanyl-Bupivacaine Versus Clonidine-Bupivacaine for Breakthrough Pain in Advanced Labor [Not yet recruiting]

Clonidine Versus Adenosine to Treat Neuropathic Pain [Active, not recruiting]

Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [Completed]

more>>